Oroxylin A, a flavonoid extracted from a Chinese medicinal plant, can induce SOD2 gene expression, glycolysis inhibition, and reduced tumor growth of transplanted human breast tumors in vivo [151]. Here, SOD2 is linked to breast neoplasm.